Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclic di-GMP as a second messenger.

Ute Römling1, Dorit Amikam

  • 1Karolinska Institutet, Microbiology and Tumor Biology Center (MTC), Box 280, SE-171 77 Stockholm, Sweden. ute.romling@ki.se

Current Opinion in Microbiology
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete genome sequences of <i>Pseudomonas aeruginosa</i> clone C strains 8277, PT31M, and SG50M isolated from the urinary tract and anthropogenic water environments.

Microbiology resource announcements·2026
Same author

Previously Uncharacterised Aliphatic Amino Acid Positions Modulate the Apparent Catalytic Activity of the EAL Domain of ZMO_1055 and Other Cyclic Di-GMP-Specific EAL Phosphodiesterases.

Microbial biotechnology·2026
Same author

First report of <i>Escherichia albertii</i> in Iran: a case study highlighting diagnostic challenges in pediatric gastroenteritis.

ASM case reports·2025
Same author

Genome sequences of six clinical isolates of <i>Candida parapsilosis</i> exhibiting different degrees and temporal regulation of biofilm formation.

Microbiology resource announcements·2025
Same author

Direct and indirect pathways linking the Lon protease to motility behaviors in the pathogen Pseudomonas aeruginosa.

PLoS pathogens·2025
Same author

Improved Isolation of Ultra-High-Molecular-Weight Genomic DNA Suitable for Third-Generation Sequencing.

Microorganisms·2025
Same journal

S-layers as natural building blocks for nanobiotechnology and synthetic biology.

Current opinion in microbiology·2026
Same journal

The role of the antimicrobial peptide nisin as a clean label food preservative.

Current opinion in microbiology·2026
Same journal

From coarse-grained metabolic rules to fine-grained control of microbial communities.

Current opinion in microbiology·2026
Same journal

Progress in engineered bacterial cancer therapies.

Current opinion in microbiology·2026
Same journal

Constraints on adaptive loss-of-function mutations during microbial metabolic interactions.

Current opinion in microbiology·2026
Same journal

Discovery of novel antimicrobials within microbiomes.

Current opinion in microbiology·2026
See all related articles

Bis-(3

Area of Science:

  • Bacterial molecular biology
  • Cell signaling
  • Biochemistry

Background:

  • Bis-(3',5')-cyclic dimeric guanosine monophosphate (c-di-GMP) is a crucial bacterial second messenger.
  • It regulates diverse cellular processes including biofilm formation, virulence, and photosynthesis.
  • GGDEF and EAL domain proteins are key enzymes controlling c-di-GMP synthesis and degradation.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of c-di-GMP signaling pathways.
  • To investigate the role of PilZ domains in c-di-GMP binding and signal transduction.
  • To explore the potential therapeutic applications of c-di-GMP signaling in eukaryotes, particularly in cancer treatment.

Main Methods:

  • Analysis of GGDEF and EAL domain protein activities.

Related Experiment Videos

  • Characterization of PilZ domains as c-di-GMP effectors.
  • Investigating bacterial signaling pathways.

    • Main Results:

    • GGDEF and EAL domain proteins exhibit tightly regulated temporal and spatial activity patterns.
    • PilZ domains are identified as candidate c-di-GMP binding domains, opening new avenues for research.
    • c-di-GMP's signaling role extends beyond bacteria, impacting eukaryotes.

    Conclusions:

    • c-di-GMP signaling is a complex and highly regulated process in bacteria.
    • The discovery of PilZ domains provides a critical tool for understanding c-di-GMP mechanisms.
    • c-di-GMP's cross-kingdom signaling functions suggest novel therapeutic strategies, including in oncology.